Rett syndrome

Summary
Synonym
  • Rett's disorder
  • cerebroatrophic hyperammonemia
Definition
A pervasive developmental disease that is characterized by normal early growth and development followed by a slowing of development, loss of purposeful use of the hands, distinctive hand movements, slowed brain and head growth, problems with walking, seizures, and intellectual disability.
Super Class
pervasive developmental disorder
Related Genes
Displaying entries 11 - 20 of 20 in total
Gene ID Gene Symbol Description Source
3897 L1CAM L1 cell adhesion molecule
5048 PAFAH1B1 platelet activating factor acetylhydrolase 1b regulatory subunit 1
7915 ALDH5A1 aldehyde dehydrogenase 5 family member A1
7957 EPM2A EPM2A glucan phosphatase, laforin
8789 FBP2 fructose-bisphosphatase 2
8869 ST3GAL5 ST3 beta-galactoside alpha-2,3-sialyltransferase 5
9370 ADIPOQ adiponectin, C1Q and collagen domain containing
22854 NTNG1 netrin G1
22933 SIRT2 sirtuin 2
23600 AMACR alpha-methylacyl-CoA racemase
Displaying 1 entry
Gene ID Gene Symbol Description Source
11450 Adipoq adiponectin, C1Q and collagen domain containing
The Human Phenotype Ontology
Displaying entries 11 - 20 of 50 in total
HPO ID HPO Term
HP:0001288 Gait disturbance
HP:0001319 Neonatal hypotonia
HP:0001332 Dystonia
HP:0001337 Tremor
HP:0001510 Growth delay
HP:0001773 Short foot
HP:0002066 Gait ataxia
HP:0002123 Generalized myoclonic seizure
HP:0002186 Apraxia
HP:0002194 Delayed gross motor development
Displaying 1 entry
Gene ID Gene Symbol Description
22854 NTNG1 netrin G1

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024